Eyegate Pharma (EYEG) Reports New U.S. Patent for Iontophoretic Delivery of Corticosteroids to the Eye
Tweet Send to a Friend
EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced that it has been granted U.S. Patent No. 9,820,935, by the U.S. Patent ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
